• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAB 14.3% 0.6¢

PATRYS LIMITED

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAB 18:18 54 16K
18:18 Last post  Raffout Comments Created with Sketch.  54  Views Created with Sketch.  16K 
PAB 28/08/24 103 30K
28/08/24 Last post  Travis Cloke Comments Created with Sketch.  103  Views Created with Sketch.  30K 
PAB 24/08/24 4 1.6K
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

BPM
19 Sep 2024
BPM MINERALS LIMITED
24/08/24 Last post  Thejerry01 Comments Created with Sketch.  4  Views Created with Sketch.  1.6K 
PAB 23/08/24 0 297
23/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  297 
PAB 27/07/24 10 6.8K
27/07/24 Last post  gassed Comments Created with Sketch.  10  Views Created with Sketch.  6.8K 
PAB 26/07/24 18 4.9K
26/07/24 Last post  orion123 Comments Created with Sketch.  18  Views Created with Sketch.  4.9K 
PAB
M & A Activities
22/07/24 13 5.4K
22/07/24 Last post  Outgoing123 Comments Created with Sketch.  13  Views Created with Sketch.  5.4K 
PAB 28/06/24 60 24K
28/06/24 Last post  Ajjax Comments Created with Sketch.  60  Views Created with Sketch.  24K 

See All Discussions arrow Created with Sketch.

Timeline

PAT-DX1 GMP specification testing update
29 Aug 09:15
 
Appendix 4G and Corporate Governance Statement
23 Aug 17:31
 
Appendix 4E and 2024 Annual Report
23 Aug 17:25
 
Further update on PAT-DX1 GMP manufacturing run
29 Jul 09:31
 
Appendix 4C - Quarterly - 30 June 2024
23 Jul 09:40
 
Update on GMP manufacturing run of PAT-DX1
01 Jul 09:03
 
View More arrow Created with Sketch.
(20min delay)
Last
0.6¢
Change
-0.001(14.3%)
Mkt cap ! $12.34M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $4.623K 770.5K

Buyers (Bids)

No. Vol. Price($)
6 3244344 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 2325084 5
View Market Depth
Last trade - 16.10pm 19/09/2024 (20 minute delay) ?
Last
0.6¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.6¢ 0.7¢ 0.6¢ 825000
Last updated 12.23pm 19/09/2024 ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.